Two cases of skin infection during psoriasis treatment with brodalumab

J Dermatol. 2018 Mar;45(3):e51-e52. doi: 10.1111/1346-8138.14119. Epub 2017 Oct 30.

Authors

Maasa Kobayashi¹, Mayumi Nagata¹, Satoe Oaku¹, Naoko Kanda¹, Yayoi Tada², Naohiko Aozasa¹

Affiliations

¹ Department of Dermatology, Kosei General Hospital, Tokyo, Japan.
² Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.

PMID: 29083051
DOI: 10.1111/1346-8138.14119

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Abscess / diagnostic imaging
Abscess / immunology*
Abscess / microbiology
Abscess / therapy
Adult
Anti-Bacterial Agents / therapeutic use
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Humanized
Dermatologic Agents / adverse effects*
Drainage
Humans
Magnetic Resonance Imaging
Male
Methicillin-Resistant Staphylococcus aureus / isolation & purification
Middle Aged
Psoriasis / drug therapy*
Psoriasis / immunology
Receptors, Interleukin-17 / antagonists & inhibitors
Receptors, Interleukin-17 / immunology
Staphylococcal Skin Infections / diagnostic imaging
Staphylococcal Skin Infections / immunology*
Staphylococcal Skin Infections / microbiology
Staphylococcal Skin Infections / therapy

Substances

Anti-Bacterial Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatologic Agents
IL17RA protein, human
Receptors, Interleukin-17
brodalumab